Affiliation:
1. Department of Medicine,1
2. Colleges of Pharmacy2 and
3. Medicine,3 University of Arizona, Tucson, Arizona
4. National Jewish Center for Immunology and Respiratory, Medicine, and Schools of Pharmacy4 and
5. Medicine,5 University of Colorado, Denver, Colorado, and
Abstract
ABSTRACT
This study was conducted in order to (i) determine the effect of food, orange juice, or antacids on the absorption of a single oral 500-mg dose of ethionamide (ETA) in healthy volunteers, including an assessment of bioequivalence, and (ii) determine ETA population pharmacokinetic (PK) parameters. The pharmacokinetics of ETA in serum was determined for 12 healthy males and females in a randomized, four-period crossover study. Volunteers received single 500-mg doses of ETA either on an empty stomach (reference) or with food, orange juice, or antacids. Serum samples were collected for 48 h and assayed by high-performance liquid chromatography. Data were analyzed by noncompartmental and population methods. Mean test/reference ratios and 90% confidence intervals were determined. No statistically significant differences were seen in the maximum concentration of ETA (
C
max
), time to maximum concentration (
T
max
), or area under the concentration-time curve from 0 h to infinity (AUC
0–∞
) between the four treatments (
P
> 0.05 by analysis of variance). The least-squares mean ratios (with confidence intervals in parentheses) for
C
max
were 105% (81.2 to 135%) after orange juice, 94% (72.8 to 121%) after food, and 88% (68.4 to 114%) after antacids. The least-squares mean ratios (with confidence intervals is in parentheses) for AUC
0–∞
were 91% (72.7 to 115%) after orange juice, 96% (76.4 to 121%) after food, and 95% (75.5 to 120%) after antacids. The mean
T
max
was slightly prolonged following antacid or food administration (2.3 to 2.6 h) compared to administration on an empty stomach or with juice (1.7 to 1.9 h). The median population PK parameters were as follows:
K
a
= 0.37 to 0.48 h
−1
,
V/F
= 2.0 to 2.8 liters/kg, CL/
F
= 56.5 to 72.2 liters/h, and terminal half-life = 1.7 to 2.1 h, where
K
a
is the absorption rate constant,
V
is the volume of distribution, and CL is clearance. The PK behavior of ETA was not significantly modified by the different conditions studied. Mean ratios for AUC ranged from 0.91 to 0.96 for the orange juice, food, and antacid treatments, indicating a minimal effect on relative bioavailability. ETA can, therefore, be administered with food if tolerance is an issue.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference28 articles.
1. Treatment of tuberculosis infection in adults and children.;American Thoracic Society;Am. J. Crit. Care Med.,1994
2. Bioequivalence and bioequivalence testing.;Balthasar J. P.;Am. J. Pharm. Educ.,1999
3. Understanding bioequivalence testing.;Benet L. Z.;Transplant. Proc.,1999
4. Bioequivalence and narrow therapeutic index drugs.;Benet L. Z.;Pharmacotherapy,1995
5. Identification de trois nouveaux metabolites de l'ethionamide: chromatographie, spectrophotometrie, polarographie.;Bieder A.;Ann. Pharm. Fr.,1966
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献